Time is running out to enter the short essay contest on the topic of Inclusivity, Diversity and Equity in Dermatology. The contest, open to any qualified resident enrolled in a dermatology training program at a Canadian medical school, will accept submissions up to Sept. 2, 2022.
This essay competition is organized by the Dermatology Industry Taskforce on Inclusion, Diversity and Equity (DiTiDE), an unincorporated, "ad hoc" committee consisting of Canadian life sciences managers and executives, physicians, and allied parties who are committed to improving the patient experience and outcomes of under-represented skin types in Canadian Dermatology, through physician education, resources and industry support.
To enter, applicants should write and submit an original short (350 to 500 words) essay on a topic of their choice relating to skin of colour and Inclusivity, Diversity and Equity in Dermatology. The essay could be about observations made during your medical training,
their personal experience, or be aspirational regarding improved dermatologic care for these members of Canadian society. Entries may be submitted in French or English.
Six finalists will be selected, with each finalist receiving a dermatology textbook prize (digital or print), publication of the winning entries on the derm.city website and in the print journal The Chronicle of Skin & Allergy, plus additional benefits to be announced.
Submissions must include:
The essayist's name
All entries must be submitted via email to: firstname.lastname@example.org
The deadline for submissions is Sept. 2, 2022
Terms of entry: The entrant must be a confirmed full-time dermatology resident in a Canadian medical school. You will need to provide a letter from your Program Director acknowledging that they are aware of and approve the submission. Original entries can be submitted in English or French as Word or PDF attachments, or as web links to Word and PDF documents. The word count per entry is 350 to 500 words, not including the title. To ensure confidentiality, patients and anyone else described in the essay must remain anonymous, with the exception of the narrator. Multiple submissions will not be considered. The decision of the judges is final.